Coronavirus vaccine developer CanSino offers shares in China’s second-most expensive initial public offering

The offer price for CanSino’s secondary listing made it the second-most expensive initial public offering in China, as the nation’s tentative signs of economic growth fuelled optimism and sparked a …
( read original story …)